Tissue and Research Pathology Services (TARPS) The Tissue and Research Pathology Services (TARPS) is an existing CCSG-funded shared resource that serves as the central support for UPCI research programs that utilize tissue materials from UPMC patients. The main objectives of TARPS are to provide a mechanism to simplify, streamline, and standardize the process of research tissue accrual and disbursement, and to provide efficient research pathology support services. The tissue accrual and disbursement function of TARPS originated in 1991 as a small service facility, with a focus on genitourinary cancers. The resource has substantially expanded in the last 23 years and now procures and disburses tissue materials from patients with a diverse array of cancers, providing support to major research projects such as the Specialized Programs Of Research Excellence (SPORE) in Head and Neck, Lung, Ovary and Skin Cancers; the Early Disease Research Network (EDRN)-related research efforts; the Hematology-Oncology Service, and several other cancer research programs.
The specific aims of TARPS are to: 1) Provide tissue and biological specimen procurement services. This includes procurement and preservation of tissue and biological specimens; storage and filing of specimens and downstream retrieval of specimens for researchers; providing appropriately sub-sampled tissue specimens with appropriate Quality assurance and Quality control of specimens; and associated data, as per the needs of the project. 2) Provide research histology services. This includes routine processing of tissue samples; design and manufacture paraffin tissue microarrays (TMAs); evaluation of novel antibodies and establishing protocols; immunohistochemical staining of conventional and TMA tissue sections, using an automated platform; and Quantitative Image Analysis and Morphometry services, when needed. 3) Annotate samples with clinical data. Data annotation is per needs of the project. TARPS utilizes resources including EMR, Pathology LIS and the UPMC Cancer Registry database for these data annotation services. 4) Provide whole slide imaging and image analysis services. TARPS has played a major role in the TCGA program having provided more than 1000 cases. Services provided by TARPS include: (1) tissue and biological specimen procurement, (2) research histology, (3) annotation of samples with clinical data, and (4) Tissue Micro-Array (TMA) facilities (5) Quantitative Image analysis and whole slide Imaging.. Future efforts include the development of a large array of TMA blocks from the TCGA cases to facilitate leveraging the molecular data generated. We are also engaged in the development of new protocols to enable profiling of numerous markers on a single slide. During the current project period investigators from all 10 Research Programs used TARPS.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA047904-29
Application #
9324837
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2017-08-01
Budget End
2018-07-31
Support Year
29
Fiscal Year
2017
Total Cost
Indirect Cost
Name
University of Pittsburgh
Department
Type
DUNS #
004514360
City
Pittsburgh
State
PA
Country
United States
Zip Code
15213
Sun, Weijing; Patel, Anuj; Normolle, Daniel et al. (2018) A phase 2 trial of regorafenib as a single agent in patients with chemotherapy-refractory, advanced, and metastatic biliary tract adenocarcinoma. Cancer :
Krivinko, Josh M; Erickson, Susan L; Ding, Ying et al. (2018) Synaptic Proteome Compensation and Resilience to Psychosis in Alzheimer's Disease. Am J Psychiatry 175:999-1009
Chartoumpekis, Dionysios V; Yagishita, Yoko; Fazzari, Marco et al. (2018) Nrf2 prevents Notch-induced insulin resistance and tumorigenesis in mice. JCI Insight 3:
Christner, Susan; Guo, Jianxia; Parise, Robert A et al. (2018) Liquid chromatography-tandem mass spectrometric assay for the quantitation of the novel radiation protective agent and radiation mitigator JP4-039 in murine plasma. J Pharm Biomed Anal 150:169-175
Laymon, Charles M; Minhas, Davneet S; Becker, Carl R et al. (2018) Image-Based 2D Re-Projection for Attenuation Substitution in PET Neuroimaging. Mol Imaging Biol 20:826-834
Benoist, Guillemette E; van der Meulen, Eric; van Oort, Inge M et al. (2018) Development and Validation of a Bioanalytical Method to Quantitate Enzalutamide and its Active Metabolite N-Desmethylenzalutamide in Human Plasma: Application to Clinical Management of Patients With Metastatic Castration-Resistant Prostate Cancer. Ther Drug Monit 40:222-229
Singh, Krishna B; Hahm, Eun-Ryeong; Rigatti, Lora H et al. (2018) Inhibition of Glycolysis in Prostate Cancer Chemoprevention by Phenethyl Isothiocyanate. Cancer Prev Res (Phila) 11:337-346
Li, Chunlei; Song, Baobao; Santos, Patricia M et al. (2018) Hepatocellular cancer-derived alpha fetoprotein uptake reduces CD1 molecules on monocyte-derived dendritic cells. Cell Immunol :
Thakur, Prakash C; Miller-Ocuin, Jennifer L; Nguyen, Khanh et al. (2018) Inhibition of endoplasmic-reticulum-stress-mediated autophagy enhances the effectiveness of chemotherapeutics on pancreatic cancer. J Transl Med 16:190
Posluszny, Donna M; Bovbjerg, Dana H; Agha, Mounzer E et al. (2018) Patient and family caregiver dyadic adherence to the allogeneic hematopoietic cell transplantation medical regimen. Psychooncology 27:354-358

Showing the most recent 10 out of 1187 publications